-+ 0.00%
-+ 0.00%
-+ 0.00%
NKGen Biotech CEO presents troculeucel neurodegenerative disease data at Biologics Manufacturing Korea 2026
Share
Listen to the news
NKGen Biotech CEO presents troculeucel neurodegenerative disease data at Biologics Manufacturing Korea 2026
  • NKGen Biotech will present on troculeucel at Biologics Manufacturing Korea 2026 in Incheon, South Korea, Sept. 17-18, 2026.
  • Talk scheduled for Sept. 18, 2026, 11:00-11:25 a.m. KST; focus on potential use in neurodegenerative diseases.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nkgen Biotech Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609100805PRIMZONEFULLFEED9821283) on September 10, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending